Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

Completed · Phase 1

Conditions studied: Neoplasms, Breast

In brief

This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).

Key facts

Study ID

NCT00148902

Run by

GlaxoSmithKline

People needed

52

Starts

2003-04-28

Expected to finish

2006-01-21

Last updated by the study team

2017-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Advanced solid tumors.
• Able to swallow oral medication.

Where it is running

• GSK Investigational Site — Detroit, Michigan, United States
• GSK Investigational Site — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.